ClinicalTrials.gg
Drug

Granulocyte Colony-Stimulating Factor clinical trials

studies test it
179
open now
25
in phase 3
31
first study started
1994

Counted the way a researcher would: Granulocyte Colony-Stimulating Factor with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Granulocyte Colony-Stimulating Factor is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Granulocyte Colony-Stimulating Factor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

G-CSF
99
Filgrastim
40
Neupogen
33
Granulocyte Colony-Stimulating Factor
17
Granulocyte Colony Stimulating Factor
14

In one entry with another drug

Given together, or one or the other

G-CSF Plus Plerixafor
8
CACAG+VEN
4
Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
3
plerixafor + G-CSF
2
Filgrastim, granulocyte-colony stimulating factor (G-CSF); subcutaneous
2
G-CSF and Plerixafor
2
Granulocyte colony-stimulating factor plus plerixafor
2

Studies by the year they started

179 studies that test it; most in 2004 (14)

Studies that test Granulocyte Colony-Stimulating Factor, by start year
YearStudies
19941
19951
19962
19981
19992
20004
20018
20026
20038
200414
20059
20065
20074
20084
20093
20109
20116
20128
20138
201410
20157
20168
20177
20189
20196
20202
20214
20222
20233
20246
20254
20268

By phase

A phase 1/2 study counts in both.

Early Phase 1
5
Phase 1
28
Phase 2
105
Phase 3
31
Phase 4
17
No phase
17

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 22 · Other 157

M.D. Anderson Cancer Center (11) · Genzyme, a Sanofi Company (10) · St. Jude Children's Research Hospital (7) · Northwestern University (6) · Washington University School of Medicine (5) · Masonic Cancer Center, University of Minnesota (5) · Chinese PLA General Hospital (4) · Post Graduate Institute of Medical Education and Research, Chandigarh (4)

Often tested with

Tested in the same studies.

Cyclophosphamide (36) · Fludarabine (24) · Plerixafor (23) · Cytarabine (21) · Filgrastim (16) · Mesna (14) · Melphalan (13) · Mycophenolic Acid (12)

Related medicines

As reviewed, each with the page that says it.

  • Filgrastim is a recombinant medicine of it, counted here with related medicines source
  • Lenograstim is a recombinant medicine of it, counted here with related medicines source

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 9

Studies that test Granulocyte Colony-Stimulating Factor.

Studies

Open first, then newest update. How each study uses Granulocyte Colony-Stimulating Factor is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 179

See all 179 studies that test Granulocyte Colony-Stimulating Factor →

Given beside what is tested · 146 — Granulocyte Colony-Stimulating Factor is usual care or a partner of the new treatment

Showing 20 of 146.

As the comparator · 15 — what is tested is compared with Granulocyte Colony-Stimulating Factor